Full-Time

Director – Pharmacology & Toxicology

Posted on 9/12/2024

4D Molecular Therapeutics

4D Molecular Therapeutics

201-500 employees

Develops gene therapies for genetic diseases

Biotechnology
Healthcare

Compensation Overview

$181k - $268kAnnually

Senior, Expert

Oakland, CA, USA

Category
Biology Lab & Research
Biology & Biotech
Requirements
  • PhD. in Toxicology, Biology, Pharmacology, or other relevant fields
  • 10+ years of professional/industry experience in preclinical pharmacology and toxicology, and biotherapeutic development experience within the Biotechnology or similar industry
  • 5+ years of management experience or team leadership experience
  • Scientific knowledge around pharmacology and toxicology
  • Proven track record in designing and executing non-GLP and GLP safety/pharmacology studies
  • Demonstrated biotherapeutic development experience including regulatory filings and interactions; knowledge of GLP and regulatory guidance; gene therapy development experience is preferred
  • Demonstrated experience in selection, review, and interaction with CROs/vendors to ensure quality, timeliness, and cost
  • Demonstrated ability to supervise the development and execution of CRO/vendor supported studies
  • Demonstrated ability to design and perform studies to support regulatory strategy for therapeutic advancement and registration
  • Demonstrated skills in managing scientific projects/programs
  • Demonstrated capability for scientific, creative, and strategic thinking, championing ideas for positions, and ability to present scientific data and concepts effectively
  • Ability to communicate – orally, in writing, and via formal presentation
  • Ability to resolve emerging issues using existing teams and/or an established network of expert consultants
  • Good interpersonal skills with the proven ability to work in a matrix team environment
Responsibilities
  • Developing strategies and directions for the department
  • Building the team and functional capabilities through hiring internally and networking externally
  • Establishing and building collaborations with relevant functions at 4DMT
  • Managing budget and headcount
  • Lead preclinical pharmacology & toxicology for 4DMT’s gene therapy programs in discovery and development stages
  • Represent preclinical toxicology on project teams and interface with internal stakeholders in discovery and development, as well as interface with regulatory agencies
  • Oversight of design, analysis, and interpretation of preclinical pharmacology and toxicology data; summarize and communicate findings, as well as provide guidance
  • Spearhead investigative efforts to elucidate the mechanism of toxicity as needed
  • Author high-quality regulatory documents including IND, CTA, BLA, NDA, IB
  • Participate in the preparation of abstracts and manuscripts for publication
  • Perform all duties in keeping with the Company’s core values, policies, and all applicable regulations
  • Accountable for CRO selection and oversight for outsourced work
  • Manage collaborations with CROs and consultants to support non-GLP and GLP studies
  • Stay up to date of regulatory requirements for gene therapy products; stay apprised of changing regulatory landscape; influence health authorities when possible
  • Contribute to CDO’s vision and mission as a senior member of the group
  • Other duties as assigned, nothing in this job description restricts management’s right to assign or reassign duties and responsibilities to this job at any time
4D Molecular Therapeutics

4D Molecular Therapeutics

View

4D Molecular Therapeutics develops gene therapies aimed at treating serious genetic diseases by delivering specific genetic material to patients' cells. The company utilizes a unique technology called Therapeutic Vector Evolution to create adeno-associated virus (AAV) vectors, which act as delivery vehicles for therapeutic genes targeting specific cells in the body. Unlike many competitors, 4DMT focuses on precision medicine for genetic disorders, including cystic fibrosis, and operates in a specialized biopharmaceutical market. Their goal is to conduct thorough research and clinical trials to ensure the safety and effectiveness of their therapies, ultimately commercializing them through direct sales or partnerships with larger pharmaceutical companies.

Company Stage

IPO

Total Funding

$170.2M

Headquarters

Emeryville, California

Founded

2013

Growth & Insights
Headcount

6 month growth

18%

1 year growth

42%

2 year growth

77%
Simplify Jobs

Simplify's Take

What believers are saying

  • 4DMT secured $75 million in Series C financing for growth and development.
  • Positive interim data from Phase 1/2 AEROW trial for 4D-710 in cystic fibrosis.
  • Astellas Pharma partnership could yield up to $962 million in future milestones.

What critics are saying

  • Potential competition from CRISPR Therapeutics and Editas Medicine in gene therapy.
  • High cost and complexity of clinical trials may cause financial strain.
  • Regulatory challenges, like FDA's clinical hold on 4D-310, can delay treatments.

What makes 4D Molecular Therapeutics unique

  • 4DMT uses proprietary Therapeutic Vector Evolution for advanced AAV vector creation.
  • The company focuses on aerosolized genetic medicines for diseases like cystic fibrosis.
  • 4DMT's R100 vector efficiently transduces the entire retina for eye disease treatments.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE